Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05622058
Title A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Aileron Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BGR

Additional content available in CKB BOOST